Iv Persantine

   
Google
 
Web NewDrugInformation.com

Iv Persantine


Drug - Iv Persantine
The trade name of the product as shown on the labeling.

Dosage - INJECTABLE; INJECTION
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Dipyridamole
Multiple ingredients are in alphabetical order.

Strength - 5MG/ML
The potency of the active ingredient(s), Dipyridamole. May repeat for multiple part products.

Applicant - BOEHRINGER INGELHEIM
The firm name holding legal responsibility for Iv Persantine. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 019817
The FDA assigned number to Iv Persantine. Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify Iv Persantine. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Dec 13, 1990
The date Iv Persantine was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Iv Persantine. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - DISCN
The group or category of approved drugs Iv Persantine is in. Format is RX, OTC, DISCN.

Applicant Full Name - Boehringer Ingelheim Pharmaceuticals Inc
The full name of the firm holding legal responsibility for the new application of Iv Persantine.

Iv Persantine